Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Nasir, Madeeha
Trujillo, Daniel
Levine, Jessica
Dwyer, Jennifer B.
Rupp, Zachary W.
and
Bloch, Michael H.
2020.
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology.
Frontiers in Psychiatry,
Vol. 11,
Issue. ,
Silote, Gabriela P.
de Oliveira, Sabrina F.S.
Ribeiro, Deidiane E.
Machado, Mayara S.
Andreatini, Roberto
Joca, Sâmia R.L.
and
Beijamini, Vanessa
2020.
Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 100,
Issue. ,
p.
109878.
Whittaker, Elizabeth
Dadabayev, Alisher R.
Joshi, Sonalee A.
and
Glue, Paul
2021.
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders.
Therapeutic Advances in Psychopharmacology,
Vol. 11,
Issue. ,
Watso, Joseph C.
Huang, Mu
Moralez, Gilbert
Cramer, Matthew N.
Hendrix, Joseph M.
Cimino, Frank A.
Belval, Luke N.
Hinojosa‐Laborde, Carmen
and
Crandall, Craig G.
2021.
Low dose ketamine reduces pain perception and blood pressure, but not muscle sympathetic nerve activity, responses during a cold pressor test.
The Journal of Physiology,
Vol. 599,
Issue. 1,
p.
67.
Song, Bijia
and
Zhu, Junchao
2021.
A Novel Application of Ketamine for Improving Perioperative Sleep Disturbances.
Nature and Science of Sleep,
Vol. Volume 13,
Issue. ,
p.
2251.
Zoladz, Phillip R.
Del Valle, Colin R.
Goodman, Cassandra S.
Dodson, Jordan L.
Smith, Ian F.
Elmouhawesse, Kara M.
Sparkman, Heather R.
Naylor, Margaret M.
and
Hopson, Elizabeth P.
2022.
Ketamine sex- and dose-dependently mitigates behavioral sequelae induced by a predator-based psychosocial stress model of post-traumatic stress disorder.
Behavioural Brain Research,
Vol. 428,
Issue. ,
p.
113895.
Luessen, Deborah J.
and
Conn, P. Jeffrey
2022.
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
Pharmacological Reviews,
Vol. 74,
Issue. 3,
p.
630.
Bali, Anoushka
Dang, Ashujot Kaur
Gonzalez, Daniel A
Kumar, Rajeswar
and
Asif, Saba
2022.
Clinical Uses of Ketamine in Children: A Narrative Review.
Cureus,
Tully, Jamie L.
Dahlén, Amelia D.
Haggarty, Connor J.
Schiöth, Helgi B.
and
Brooks, Samantha
2022.
Ketamine treatment for refractory anxiety: A systematic review.
British Journal of Clinical Pharmacology,
Vol. 88,
Issue. 10,
p.
4412.
Arpacı, Ayse Hande
Çalıskan, Hasan
Gunes, Emel
and
Işık, Berrin
2022.
Effects of the Recurrent and Different Doses of Ketamine Exposure on
Anxiety-like Behaviors and Locomotor Activity in Juvenile Rats.
Current Alzheimer Research,
Vol. 19,
Issue. 14,
p.
933.
Hartland, Hannah
Mahdavi, Kimia
Jelen, Luke A
Strawbridge, Rebecca
Young, Allan H
and
Alexander, Laith
2023.
A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects.
Journal of Psychopharmacology,
Vol. 37,
Issue. 8,
p.
764.
Temizer, Rose
Chen, Yi‐Wen
and
Aoki, Chiye
2023.
Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex.
Synapse,
Vol. 77,
Issue. 1,
Vitek, Grace
Langenfeld, Robert
Walters, Ryan W
Elson, Alisandrea
Driscoll, David
and
Ramaswamy, Sriram
2023.
Therapeutic and Safety Outcomes of Intravenous Ketamine for Treatment-refractory Depression in a Veteran Population: A Case Series.
Military Medicine,
Vol. 188,
Issue. 7-8,
p.
e2242.
Peskin, Evan
Gudin, Jeffrey
and
Schatman, Michael E
2023.
Increased Demand for Ketamine Infusions and Associated Complexities.
Journal of Pain Research,
Vol. Volume 16,
Issue. ,
p.
295.
Whinkin, Emily
Eparwa, Therry Rose J.
Julseth, Michelle C.
Schneider, Andrea
and
Aggarwal, Sunil K.
2023.
Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Dehestani, Sina
Mohammadpour, Amir Houshang
Sadjadi, Seyed Alireza
Sathyapalan, Thozhukat
and
Sahebkar, Amirhossein
2023.
Clinical use of ketamine in psychiatric disorders.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 181,
Issue. 6,
p.
495.
Karbasi Amel, Afsaneh
and
Hosseini, Farzaneh
2023.
A Comparison of the Anti-Anxiety Effects of Oral Ketamine and Fluvoxamine in Children with Separation Anxiety Disorder Manifesting as School Refusal.
Advanced Biomedical Research,
Vol. 12,
Issue. 1,
Glavonic, Emilija
Dragic, Milorad
Mitic, Milos
Aleksic, Minja
Lukic, Iva
Ivkovic, Sanja
and
Adzic, Miroslav
2024.
Ketamine’s Amelioration of Fear Extinction in Adolescent Male Mice Is Associated with the Activation of the Hippocampal Akt-mTOR-GluA1 Pathway.
Pharmaceuticals,
Vol. 17,
Issue. 6,
p.
669.
Wang, Jun‐Meng
Wang, Yue‐Mei
Zhu, Yuan‐Bing
Cui, Chan
Feng, Tong
Huang, Qin
Liu, Shu‐Qing
and
Wu, Qiao‐Feng
2024.
Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1.
CNS Neuroscience & Therapeutics,
Vol. 30,
Issue. 4,
Patil, Ashish Suresh
and
Koul, Summon
2024.
Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression.
Current Pharmaceutical Design,
Vol. 30,
Issue. 33,
p.
2587.